256 related articles for article (PubMed ID: 9254691)
1. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease.
Kreiss DS; Mastropietro CW; Rawji SS; Walters JR
J Neurosci; 1997 Sep; 17(17):6807-19. PubMed ID: 9254691
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
Zahr NM; Martin LP; Waszczak BL
Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
[TBL] [Abstract][Full Text] [Related]
3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
4. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Hassani OK; Féger J
Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
[TBL] [Abstract][Full Text] [Related]
5. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
Ruskin DN; Marshall JF
Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628
[TBL] [Abstract][Full Text] [Related]
7. Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa.
Zhu Z; Bartol M; Shen K; Johnson SW
Brain Res; 2002 Jul; 945(1):31-40. PubMed ID: 12113949
[TBL] [Abstract][Full Text] [Related]
8. Apomorphine and dopamine D(1) receptor agonists increase the firing rates of subthalamic nucleus neurons.
Kreiss DS; Anderson LA; Walters JR
Neuroscience; 1996 Jun; 72(3):863-76. PubMed ID: 9157332
[TBL] [Abstract][Full Text] [Related]
9. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
Ruskin DN; Bergstrom DA; Walters JR
J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
[TBL] [Abstract][Full Text] [Related]
11. Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology.
Tofighy A; Abbott A; Centonze D; Cooper AJ; Noor E; Pearce SM; Puntis M; Stanford IM; Wigmore MA; Lacey MG
Neuroscience; 2003; 116(1):157-66. PubMed ID: 12535949
[TBL] [Abstract][Full Text] [Related]
12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
Tseng KY; Riquelme LA; Belforte JE; Pazo JH; Murer MG
Eur J Neurosci; 2000 Jan; 12(1):247-56. PubMed ID: 10651879
[TBL] [Abstract][Full Text] [Related]
14. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
16. Multisecond oscillations in firing rate in the basal ganglia: robust modulation by dopamine receptor activation and anesthesia.
Ruskin DN; Bergstrom DA; Kaneoke Y; Patel BN; Twery MJ; Walters JR
J Neurophysiol; 1999 May; 81(5):2046-55. PubMed ID: 10322046
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
18. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway.
Ni Z; Gao D; Bouali-Benazzouz R; Benabid AL; Benazzouz A
Eur J Neurosci; 2001 Jul; 14(2):373-81. PubMed ID: 11553287
[TBL] [Abstract][Full Text] [Related]
19. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
[TBL] [Abstract][Full Text] [Related]
20. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
